Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission

NCT02937779 is registered in ClinicalTrials.gov with ANRS, Emerging Infectious Diseases as lead sponsor.

NCT NCT02937779
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02937779 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission
Lead sponsor
ANRS, Emerging Infectious Diseases
Phase
Phase 4
Overall status
Unknown status
Start date
October 4, 2017
Completion date
March 31, 2020
Enrollment
933 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b chronic infection, pregnancy